NINTEDANIB TEVA 150 mg, capsule molle — 60 plaquettes prédécoupées unitaires OPA : polyamide orienté aluminium PVC-Aluminium de 1 capsule

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930289198
  • CIP7 3028919
  • CIS 65683679

What the source publishes

Holder
TEVA SANTE
Active ingredients
NINTÉDANIB, ÉSILATE DE NINTÉDANIB
Form
capsule molle
Package
60 plaquettes prédécoupées unitaires OPA : polyamide orienté aluminium PVC-Aluminium de 1 capsule
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services PNEUMOLOGIE ; prescription réservée aux spécialistes et services RHUMATOLOGIE ; prescription hospitalière ; liste I
Marketing status
Déclaration de commercialisation
Authorised on
2024-02-01
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930289198
{
  "cis": "65683679",
  "cip7": "3028919",
  "form": "capsule molle",
  "name": "NINTEDANIB TEVA 150 mg, capsule molle — 60 plaquettes prédécoupées unitaires OPA : polyamide orienté aluminium PVC-Aluminium de 1 capsule",
  "cip13": "3400930289198",
  "holder": "TEVA SANTE",
  "routes": [
    "orale"
  ],
  "holders": [
    "TEVA SANTE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "608.16",
  "authorisedOn": "2024-02-01",
  "compositions": [
    {
      "name": "NINTÉDANIB",
      "nature": "FT",
      "strength": "150 mg",
      "linkageNumber": "1",
      "substanceCode": "41187",
      "dosageReference": "une capsule",
      "pharmaceuticalElement": "capsule"
    },
    {
      "name": "ÉSILATE DE NINTÉDANIB",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "52826",
      "dosageReference": null,
      "pharmaceuticalElement": "capsule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services PNEUMOLOGIE ; prescription réservée aux spécialistes et services RHUMATOLOGIE ; prescription hospitalière ; liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "607.14",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "NINTEDANIB TEVA 150 mg, capsule molle",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "60 plaquettes prédécoupées unitaires OPA : polyamide orienté aluminium PVC-Aluminium de 1 capsule",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30%"
  ],
  "marketingDeclaredOn": "2026-04-09",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "NINTÉDANIB",
    "ÉSILATE DE NINTÉDANIB"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services MEDECINE INTERNE",
    "prescription réservée aux spécialistes et services PNEUMOLOGIE",
    "prescription réservée aux spécialistes et services RHUMATOLOGIE",
    "prescription hospitalière",
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930289198"